Search research articles
Contact Us
Filters
Showing results (21-30 of 138) with videos related to
Page
of 14
Sort By:
Gynecologic Oncology
|
July 24, 2010
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer
Gabriella Ferrandina, Andrea Marcellusi, Francesco Saverio Mennini, et al.
BMC Cancer
|
July 9, 2009
CD133 antigen expression in ovarian cancer
Gabriella Ferrandina, Enrica Martinelli, Marco Petrillo, et al.
Molecular and Cellular Endocrinology
|
May 13, 2009
Expression and subcellular localization of CRH and its receptors in human endometrial cancer
Fiorella Miceli, Franco O Ranelletti, Enrica Martinelli, et al.
Archives of Gynecology and Obstetrics
|
September 27, 2018
Secondary cytoreduction in ovarian cancer: who really benefits?
Maria Teresa Giudice, Marco D'Indinosante, Serena Cappuccio, et al.
Pathologica
|
April 28, 2023
Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing
Renato Lobrano, Alessandra Manca, Maria Cristina Sini, et al.
Human Pathology
|
July 7, 2014
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery
Gian Franco Zannoni, Marco Petrillo, Valerio Gaetano Vellone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 27, 2010
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer
Alessandra Battaglia, Alexia Buzzonetti, Enrica Martinelli, et al.
Annals of Surgical Oncology
|
June 4, 2015
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study
Marco Petrillo, Ida Paris, Giuseppe Vizzielli, et al.
Gynecologic Oncology
|
May 13, 2017
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer
Marta De Donato, Marco Petrillo, Enrica Martinelli, et al.
Cancer Chemotherapy and Pharmacology
|
April 13, 2007
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge
Gabriella Ferrandina, Francesco Legge, Valentina Mey, et al.
Page
of 14
Search research articles
Search
Showing results (21-30 of 138) with videos related to
Sort By:
Page
of 14
Gynecologic Oncology
|
July 24, 2010
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer
Gabriella Ferrandina, Andrea Marcellusi, Francesco Saverio Mennini, et al.
BMC Cancer
|
July 9, 2009
CD133 antigen expression in ovarian cancer
Gabriella Ferrandina, Enrica Martinelli, Marco Petrillo, et al.
Molecular and Cellular Endocrinology
|
May 13, 2009
Expression and subcellular localization of CRH and its receptors in human endometrial cancer
Fiorella Miceli, Franco O Ranelletti, Enrica Martinelli, et al.
Archives of Gynecology and Obstetrics
|
September 27, 2018
Secondary cytoreduction in ovarian cancer: who really benefits?
Maria Teresa Giudice, Marco D'Indinosante, Serena Cappuccio, et al.
Pathologica
|
April 28, 2023
Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing
Renato Lobrano, Alessandra Manca, Maria Cristina Sini, et al.
Human Pathology
|
July 7, 2014
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery
Gian Franco Zannoni, Marco Petrillo, Valerio Gaetano Vellone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 27, 2010
Selective changes in the immune profile of tumor-draining lymph nodes after different neoadjuvant chemoradiation regimens for locally advanced cervical cancer
Alessandra Battaglia, Alexia Buzzonetti, Enrica Martinelli, et al.
Annals of Surgical Oncology
|
June 4, 2015
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study
Marco Petrillo, Ida Paris, Giuseppe Vizzielli, et al.
Gynecologic Oncology
|
May 13, 2017
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer
Marta De Donato, Marco Petrillo, Enrica Martinelli, et al.
Cancer Chemotherapy and Pharmacology
|
April 13, 2007
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge
Gabriella Ferrandina, Francesco Legge, Valentina Mey, et al.
Page
of 14